These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37939099)

  • 21. Pretreatment loss to follow-up of tuberculosis patients in Chennai, India: a cohort study with implications for health systems strengthening.
    Thomas BE; Subbaraman R; Sellappan S; Suresh C; Lavanya J; Lincy S; Raja AL; Javeed B; Kokila S; Arumugam S; Swaminathan S; Mayer KH
    BMC Infect Dis; 2018 Mar; 18(1):142. PubMed ID: 29587651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "Better to Die Than Take These Medicines": A Community-Based Qualitative Study on the Determinants of Treatment Loss-to-Follow-Up in Tuberculosis Patients in District Faridabad, Haryana, India.
    Khaitan A; Rai SK; Krishnan A; Gupta SK; Kant S; Khilnani GC
    Cureus; 2022 May; 14(5):e25030. PubMed ID: 35591891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local staff making sense of their tuberculosis data: key to quality care and ending tuberculosis.
    Heldal E; Dlodlo RA; Mlilo N; Nyathi BB; Zishiri C; Ncube RT; Siziba N; Sandy C
    Int J Tuberc Lung Dis; 2019 May; 23(5):612-618. PubMed ID: 31097071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss to Follow-Up Risk among HIV Patients on ART in Zimbabwe, 2009-2016: Hierarchical Bayesian Spatio-Temporal Modeling.
    Matsena Zingoni Z; Chirwa T; Todd J; Musenge E
    Int J Environ Res Public Health; 2022 Sep; 19(17):. PubMed ID: 36078729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with unfavourable tuberculosis treatment outcomes in Lusaka, Zambia, 2015: a secondary analysis of routine surveillance data.
    Nanzaluka FH; Chibuye S; Kasapo CC; Langa N; Nyimbili S; Moonga G; Kapata N; Kumar R; Chongwe G
    Pan Afr Med J; 2019; 32():159. PubMed ID: 31308862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interpreting Mamelodi Community-Oriented Primary Care data on tuberculosis loss to follow-up through the lens of intersectionality.
    Ilunga BB; Eales OO; Marcus TS; Smith S; Hugo JF
    Afr J Prim Health Care Fam Med; 2020 Feb; 12(1):e1-e6. PubMed ID: 32129651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment outcomes of adult patients with recurrent tuberculosis in relation to HIV status in Zimbabwe: a retrospective record review.
    Takarinda KC; Harries AD; Srinath S; Mutasa-Apollo T; Sandy C; Mugurungi O
    BMC Public Health; 2012 Feb; 12():124. PubMed ID: 22329930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tuberculosis care cascade in Zambia - identifying the gaps in order to improve outcomes: a population-based analysis.
    Lungu P; Kerkhoff AD; Kasapo CC; Mzyece J; Nyimbili S; Chimzizi R; Silumesii A; Kagujje M; Subbaraman R; Muyoyeta M; Malama K
    BMJ Open; 2021 Aug; 11(8):e044867. PubMed ID: 34376439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for HIV Among Patients at Tuberculosis Clinics - Results from Population-Based HIV Impact Assessment Surveys, Malawi, Zambia, and Zimbabwe, 2015-2016.
    Kothegal N; Wang A; Jonnalagadda S; MacNeil A; Radin E; Brown K; Mugurungi O; Choto R; Balachandra S; Rogers JH; Musuka G; Kalua T; Odo M; Auld A; Gunde L; Kim E; Payne D; Lungu P; Mulenga L; Hassani AS; Nkumbula T; Patel H; Parekh B; Voetsch AC
    MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(10):342-345. PubMed ID: 33705366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The epidemiology of drug-resistant tuberculosis in Bulawayo and Matabeleland South provinces, Zimbabwe 2017.
    Mugauri Dumisani H; Chirenda J; Juru T; Mugurungi O; Shambira G; Gombe N; Tshimanga M
    IJID Reg; 2022 Jun; 3():37-43. PubMed ID: 35755478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tuberculosis Case Finding Cascade and Treatment Outcomes among Male Inmates in Two Prisons in Zimbabwe.
    Mandizvidza A; Dlodlo RA; Chinnakali P; Mugauri HD; Dube F; Gaka E; Nembaware J; Nyambi S; Masunungure B; Garauzive D
    Tuberc Res Treat; 2020; 2020():5829471. PubMed ID: 32695509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics and treatment outcomes of tuberculosis patients who "transfer-in" to health facilities in Harare City, Zimbabwe: a descriptive cross-sectional study.
    Takarinda KC; Harries AD; Mutasa-Apollo T; Sandy C; Mugurungi O
    BMC Public Health; 2012 Nov; 12():981. PubMed ID: 23150928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hidden loss to follow-up among tuberculosis patients managed by public-private mix institutions in South Korea.
    Kim HW; Park S; Min J; Sun J; Shin AY; Ha JH; Park JS; Lee SS; Lipman M; Abubakar I; Stagg HR; Kim JS
    Sci Rep; 2022 Jul; 12(1):12362. PubMed ID: 35859107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T-BACCO SCORE: A predictive scoring tool for tuberculosis (TB) loss to follow-up among TB smokers.
    Sharani ZZ; Ismail N; Yasin SM; Isa MR; Razali A; Sherzkawee MA; Ismail AI
    PLoS One; 2023; 18(6):e0287374. PubMed ID: 37319310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health Screening Strategies for Artisanal and Small-Scale Miners for Tuberculosis, Human Immunodeficiency Virus and Silicosis: A Case of the USAID-Supported Kunda Nqob'iTB Project in Zimbabwe.
    Moyo D; Kavenga F; Moyo F; Muzvidziwa O; Madziva G; Chigaraza B; Ncube M; Madadangoma P; Masvingo H; Muperi TC; Mando TC; Ncube RT
    Int J Environ Res Public Health; 2024 Jan; 21(1):. PubMed ID: 38248534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of loss to follow-up among adult tuberculosis patients in Southern Ethiopia: a retrospective follow-up study.
    Watumo D; Mengesha MM; Gobena T; Gebremichael MA; Jerene D
    BMC Public Health; 2022 May; 22(1):976. PubMed ID: 35568853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A feasibility study using time-driven activity-based costing as a management tool for provider cost estimation: lessons from the national TB control program in Zimbabwe in 2018.
    Chirenda J; Nhlema Simwaka B; Sandy C; Bodnar K; Corbin S; Desai P; Mapako T; Shamu S; Timire C; Antonio E; Makone A; Birikorang A; Mapuranga T; Ngwenya M; Masunda T; Dube M; Wandwalo E; Morrison L; Kaplan R
    BMC Health Serv Res; 2021 Mar; 21(1):242. PubMed ID: 33736629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and predictors of LTFU among adults with TB/HIV co-infection in two governmental hospitals, Mekelle, Ethiopia, 2009-2016: survival model approach.
    Gezae KE; Abebe HT; Gebretsadik LG
    BMC Infect Dis; 2019 Feb; 19(1):107. PubMed ID: 30717705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Factors for Unfavorable Outcomes of Tuberculosis in Korea: Implications for Patient-Centered Care in Tuberculosis Treatment.
    Hong HY; Park Y; Yong SH; Woo A; Leem AY; Lee SH; Chung KS; Lee SH; Kim SY; Kim EY; Jung JY; Park MS; Kim YS; Shin SJ; Kang YA
    J Korean Med Sci; 2024 Jan; 39(2):e4. PubMed ID: 38225780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isoniazid mono-resistant tuberculosis: Time to take it seriously.
    Garg K; Saini V; Dhillon R; Agarwal P
    Indian J Tuberc; 2019 Apr; 66(2):247-252. PubMed ID: 31151492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.